Michael Egholm is President & CEO of STANDARD BIOTOOLS INC.. Currently has a direct ownership of 1.5 Million shares of LAB, which is worth approximately $2.25 Million. The most recent transaction as insider was on Aug 20, 2024, when has been sold 29,093 shares (Common Stock) at a price of $1.91 per share, resulting in proceeds of $55,567. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.5M
0% 3M change
627.56% 12M change
Total Value Held $2.25 Million

Michael Egholm Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 20 2024
SELL
Payment of exercise price or tax liability
$55,567 $1.91 p/Share
29,093 Reduced 1.9%
1,502,499 Common Stock
May 20 2024
BUY
Grant, award, or other acquisition
-
1,000,000 Added 39.5%
1,531,592 Common Stock
Apr 08 2024
SELL
Payment of exercise price or tax liability
$277,948 $2.71 p/Share
102,564 Reduced 16.17%
531,592 Common Stock
Apr 05 2024
BUY
Grant, award, or other acquisition
-
212,126 Added 25.07%
634,156 Common Stock
Apr 04 2024
BUY
Exercise of conversion of derivative security
-
196,512 Added 31.77%
422,030 Common Stock
Jan 05 2024
BUY
Grant, award, or other acquisition
-
9,006 Added 3.84%
225,518 Common Stock
Apr 04 2023
BUY
Exercise of conversion of derivative security
-
196,512 Added 48.76%
206,512 Common Stock

Also insider at

ISO
IsoPlexis Corp Healthcare
ME

Michael Egholm

President & CEO
South San Francisco, CA

Track Institutional and Insider Activities on LAB

Follow STANDARD BIOTOOLS INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells LAB shares.

Notify only if

Insider Trading

Get notified when an Standard Biotools Inc. insider buys or sells LAB shares.

Notify only if

News

Receive news related to STANDARD BIOTOOLS INC.

Track Activities on LAB